Abstract
Subcutaneous immune globulin (IGSC) offers the convenience of self-administration, fewer systemic reactions, and more stable IgG levels compared to intravenous IG (IVIG). The Life Quality Index (LQI) is an instrument to evaluate health-related quality of life (QoL) and treatment satisfaction among patients receiving IG therapy and has been previously applied to product switches. We report QoL survey results for patients transitioned to IGSC 16.5% (Cutaquig®) from IVIG or alternative IGSC in a real-world setting.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
